India · Delayed Price · Currency is INR Windlas Biotech Statistics
Total Valuation
Windlas Biotech has a market cap or net worth of INR 16.87 billion. The enterprise value is 14.58 billion.
| Market Cap | 16.87B |
| Enterprise Value | 14.58B |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | Jul 21, 2025 |
Share Statistics
| Current Share Class | 20.96M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 62.40% |
| Owned by Institutions (%) | 9.83% |
| Float | 7.60M |
Valuation Ratios
The trailing PE ratio is 25.27.
| PE Ratio | 25.27 |
| Forward PE | n/a |
| PS Ratio | 1.94 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.84 |
| EV / Sales | 1.68 |
| EV / EBITDA | 13.14 |
| EV / EBIT | 19.62 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | n/a |
| Interest Coverage | 15.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 18.57% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.45M |
| Profits Per Employee | 495,892 |
| Employee Count | 1,346 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Windlas Biotech has paid 208.92 million in taxes.
| Income Tax | 208.92M |
| Effective Tax Rate | 23.84% |
Stock Price Statistics
The stock price has decreased by -6.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.45% |
| 50-Day Moving Average | 798.11 |
| 200-Day Moving Average | 896.99 |
| Relative Strength Index (RSI) | 47.16 |
| Average Volume (20 Days) | 2,735 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Windlas Biotech had revenue of INR 8.68 billion and earned 667.47 million in profits. Earnings per share was 31.44.
| Revenue | 8.68B |
| Gross Profit | 3.30B |
| Operating Income | 742.98M |
| Pretax Income | 876.39M |
| Net Income | 667.47M |
| EBITDA | 1.09B |
| EBIT | 742.98M |
| Earnings Per Share (EPS) | 31.44 |
Balance Sheet
The company has 2.61 billion in cash and 312.09 million in debt, with a net cash position of 2.29 billion.
| Cash & Cash Equivalents | 2.61B |
| Total Debt | 312.09M |
| Net Cash | 2.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.34B |
| Book Value Per Share | 254.44 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.00%, with operating and profit margins of 8.56% and 7.69%.
| Gross Margin | 38.00% |
| Operating Margin | 8.56% |
| Pretax Margin | 10.09% |
| Profit Margin | 7.69% |
| EBITDA Margin | 12.50% |
| EBIT Margin | 8.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.80, which amounts to a dividend yield of 0.68%.
| Dividend Per Share | 5.80 |
| Dividend Yield | 0.68% |
| Dividend Growth (YoY) | 5.45% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.05% |
| Earnings Yield | 3.96% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |